GILD
Gilead Sciences Inc
150.60$
+0.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 15.2% | 12.3% | 14.0% | 16.7% | 21.9% | 20.8% | 18.5% | 24.2% | 20.7% | 21.4% | 21.7% | 21.2% | |
| 84.8% | 87.7% | 86.0% | 83.3% | 78.1% | 79.2% | 81.5% | 75.8% | 79.3% | 100.0% | 78.3% | 78.8% | |
| 11.5% | 9.2% | 16.8% | 14.3% | 17.7% | 18.1% | 20.4% | 16.9% | 18.2% | 21.1% | 20.5% | 19.7% | |
| 12.0% | 10.5% | 11.2% | 14.9% | 18.3% | 16.0% | 17.5% | 16.5% | 17.9% | 24.0% | 9.2% | 7.4% | |
| 23.5% | 19.7% | 28.0% | 29.2% | 36.0% | 37.6% | 65.0% | 39.5% | 52.4% | 43.5% | 72.5% | 39.1% | |
| 61.3% | 68.0% | 58.0% | 54.1% | 37.1% | 19.1% | 16.5% | 36.3% | 26.9% | 28.0% | 5.8% | 39.7% | |
| 1.7% | 2.1% | 3.2% | 4.3% | 4.9% | 4.4% | 4.0% | 3.7% | 3.4% | 3.5% | 3.4% | 3.5% | |
| 59.7% | 66.4% | 56.3% | 51.8% | 35.2% | 23.0% | 6.8% | 30.3% | 21.3% | 25.3% | 2.4% | 33.3% | |
| 11.2% | 10.9% | 11.9% | 34.0% | 10.6% | -0.9% | 6.4% | 7.6% | 4.6% | -4.6% | 0.7% | 4.4% | |
| 48.6% | 55.5% | 44.4% | 17.7% | 24.7% | 24.0% | 0.5% | 22.8% | 16.8% | 20.9% | 1.7% | 28.9% | |
| 65.6% | 71.8% | 63.2% | 61.0% | 46.6% | 33.7% | 16.7% | 41.5% | 32.4% | 28.0% | 15.4% | 46.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.